Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

MIPI

Molecular Insight Pharmaceuticals (MM) (MIPI)

Molecular Insight Pharmaceuticals (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:MIPI
DateHeureSourceTitreSymboleSociété
21/12/201001h42MarketwiredMolecular Insight Announces NASDAQ Decision to Delist Common Stock and Transfer to OTCQB(TM) MarketplaceNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
17/12/201017h18Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
14/12/201022h39Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
10/12/201004h46MarketwiredMolecular Insight Announces $45-Million Financing Commitment, Chapter 11 Filing, Corporate Restructuring and Management ChangesNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
03/12/201001h38MarketwiredMolecular Insight Receives Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
04/11/201018h43Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
04/11/201013h21MarketwiredMolecular Insight Pharmaceuticals, Inc. Announces Third Quarter 2010 Financial and Operational ResultsNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
19/10/201022h30MarketwiredMolecular Insight Pharmaceuticals Data Indicate Trofex(TM) May Enable Visualization and Monitoring of Response to Prostate CanceNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
19/10/201022h01MarketwiredMolecular Insight Announces Resignation of Chief Medical OfficerNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
14/10/201022h49MarketwiredMolecular Insight Pharmaceuticals Presents Positive Data From Clinical Studies Comparing Trofex(TM) and ProstaScint(R) for DetecNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
08/10/201014h00MarketwiredMolecular Insight Pharmaceuticals Receives NASDAQ Notification LettersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
06/10/201017h47MarketwiredMolecular Insight Receives Eleventh Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
17/09/201020h58Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
17/09/201017h16MarketwiredMolecular Insight Receives Tenth Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
09/09/201014h00MarketwiredMolecular Insight Receives Ninth Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
01/09/201014h01MarketwiredMolecular Insight Receives Eighth Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
30/08/201023h11Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
17/08/201014h04MarketwiredMolecular Insight Receives Seventh Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
02/08/201022h01MarketwiredMolecular Insight Receives Sixth Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
16/07/201014h01MarketwiredMolecular Insight Receives Fifth Extension of Waiver Agreement with Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
14/07/201014h01MarketwiredMolecular Insight Pharmaceuticals' Zemiva Phase 2 Data Published in Journal of the American College of CardiologyNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
02/07/201014h09MarketwiredMolecular Insight Receives Fourth Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
01/07/201012h03Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
30/06/201020h49Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/A)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
25/06/201014h01MarketwiredMolecular Insight Pharmaceuticals Receives NASDAQ Notification LetterNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
23/06/201022h01MarketwiredMolecular Insight Pharmaceuticals Presents Positive Data From Azedra(TM) Phase 2a Clinical Trial in Neuroblastoma TumorsNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
22/06/201014h01MarketwiredMolecular Insight Receives Third Extension of Waiver Agreement With Bond holdersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
16/06/201012h50GlobeNewswire Inc.Stock Alert for Molecular Insight Pharmaceuticals Inc. Issued by MicroStockProfitNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
08/06/201022h30MarketwiredMolecular Insight Pharmaceuticals Presents Oncology Data at Society of Nuclear Medicine 2010 Annual MeetingNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
18/05/201014h00MarketwiredMolecular Insight Receives Second Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:MIPI

Dernières Valeurs Consultées

Delayed Upgrade Clock